Haleon has announced a voluntary recall of two Robitussin cough medicines due to microbial contamination. The cough syrups being recalled are Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult. The company emphasized that it has not received any reports of adverse events related to the recall, but still issued a warning about the potential risks associated with the affected products.
The use of the contaminated cough medicines could lead to severe or life-threatening adverse events such as fungemia, which refers to the presence of fungi or yeasts in the blood, or disseminated fungal infection in immunocompromised individuals. However, the likelihood of life-threatening infections occurring in nonimmunocompromised consumers is low.
Haleon is taking proactive measures to address the issue by notifying distributors and customers to return the recalled products. Individuals who have purchased the affected cough syrups listed in the recall are urged to return them. It’s important to note that the recall of eight lots of the medicine is being conducted in collaboration with the U.S. Food and Drug Administration, emphasizing the seriousness of the situation.
The safety and well-being of consumers is Haleon’s utmost priority, leading to this prompt recall to prevent any potential health risks associated with the use of the affected cough medicines. By taking swift action and working closely with regulatory authorities, Haleon is demonstrating its commitment to safeguarding public health.
In response to the recall, consumers are encouraged to stay informed and act upon the company’s notification to return the products. Additionally, individuals should consult healthcare professionals if they have used the recalled cough medicines and have any concerns about their health.
Haleon’s dedication to transparency and accountability is evident through its proactive approach in addressing the issue. The company remains vigilant in ensuring the safety and quality of its products, and will continue to communicate openly with the public and regulatory agencies as they work to resolve the matter.
As a responsible and reputable healthcare company, Haleon is committed to addressing the situation and minimizing any potential risks to consumers, reinforcing its dedication to upholding the highest standards of product safety and effectiveness.
Source link
